Clinical Trial Update: Acthar SLE (Systemic Lupus Erythematosus) [Phase 4]

View source ↗

Summary

Phase 4 clinical trial for Repository Corticotropin Injection in systemic lupus erythematosus was withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Systemic Lupus Erythematosus

Drugs mentioned

• repository corticotropin injection (repository corticotropin injection)

Snippet

Sponsor: NYU Langone Health | Conditions: Systemic Lupus Erythematosus (SLE), Repository Corticotropin Injection | Phase 4 | Status: WITHDRAWN